The weekly litigation news digest is live. Subscribe now

IP Verse

Ono Pharmaceutical competitive analysis

Loading summary...

Latest patents of Ono Pharmaceutical opposed by its competitors

Explore Ono Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 11, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2439273
Feb 27, 2019Human Monoclonal Antibodies To Programmed Death 1(Pd-1) And Methods For Treating Cancer Using Anti-Pd-1 Antibodies Alone Or In Combination With Other Immunotherapeutics1

Latest PTAB cases involving Ono Pharmaceutical

Discover the latest PTAB cases involving Ono Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Dec 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Ono Pharmaceutical

IPR2016-01219Jun 30, 2016MERCK SHARP & DOHMEONO PHARMACEUTICALTerminated-Settled
IPR2016-01217Jun 29, 2016MERCK SHARP & DOHMEONO PHARMACEUTICALTerminated-Settled
IPR2016-01218Jun 29, 2016MERCK SHARP & DOHMEONO PHARMACEUTICALTerminated-Settled
IPR2016-01221Jun 29, 2016MERCK SHARP & DOHMEONO PHARMACEUTICALTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Ono Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ONO PHARMACEUTICAL - 1 - 4
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBB12 - - -
MERCK SHARP & DOHME2042555